Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BRCA-DIRECT: Randomised Evaluation in Women Diagnosed With Breast Cancer of Digitally-delivered Pre-test Information for BRCA-testing

NCT04842799 is registered in ClinicalTrials.gov with Institute of Cancer Research, United Kingdom as lead sponsor.

NCT NCT04842799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04842799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BRCA-DIRECT: Randomised Evaluation in Women Diagnosed With Breast Cancer of Digitally-delivered Pre-test Information for BRCA-testing
Lead sponsor
Institute of Cancer Research, United Kingdom
Phase
Not applicable
Overall status
Completed
Start date
July 5, 2021
Completion date
January 16, 2023
Enrollment
1,140 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasm female